Related Experiment Videos
Lipid lowering with dietary supplements: focus on diabetes
1Institute of Nutraceuticals and Functional Foods, Laval University, Pavillon des Services, Bureau 2602, 2440, Boulevard Hochelaga, Québec, Canada G1V 0A6. iwona.rudkowska@fsaa.ulaval.ca
Maturitas
|March 31, 2012
Summary
Dietary supplements like psyllium show promise in managing cardiovascular disease risk factors in type 2 diabetes patients. While psyllium improved lipid profiles and glycemic control, results for garlic and green tea remain uncertain, necessitating further research.
Area of Science:
- Nutritional Science
- Metabolic Disorders
- Cardiovascular Health
Background:
- Cardiovascular disease (CVD) is the leading cause of death in type 2 diabetes (T2DM).
- Dyslipidemia and hyperglycemia are key modifiable risk factors for CVD in T2DM.
- Dietary supplement use is globally prevalent, prompting investigation into their therapeutic potential.
Purpose of the Study:
- To review current meta-analyses and clinical studies on psyllium, garlic, and green tea supplements.
- To evaluate the impact of these supplements on plasma lipids, glycemic control, and CVD risk factors in T2DM patients.
Main Methods:
- Systematic review of recent meta-analyses and clinical trials.
- Focus on studies involving psyllium, garlic, and green tea supplementation.
- Analysis of effects on lipid profiles, HbA1c, and other CVD risk markers.
Main Results:
- Psyllium supplementation demonstrated significant improvements in lipid profiles and glycemic control in T2DM patients.
- Evidence for the efficacy of garlic and green tea in managing dyslipidemia and hyperglycemia in T2DM is inconclusive.
- Dietary supplements may offer a complementary approach to managing CVD risk factors in T2DM.
Conclusions:
- Psyllium may be a beneficial adjunct therapy for improving metabolic parameters in type 2 diabetes.
- Further high-quality intervention studies are required to confirm the benefits of garlic and green tea for CVD risk reduction in T2DM.
- Dietary supplements represent a potential, but not yet fully established, therapeutic avenue for T2DM management.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...